Disease Info Card

Nocturnal Myoclonus Syndrome

Information about Nocturnal Myoclonus Syndrome: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Nocturnal Myoclonus Syndrome

Most recent studies have shown that Nocturnal Myoclonus Syndrome shares some biological mechanisms with agitation, apnea, attention-deficit-hyperactivity-disorder, behavior-disorders, depressive-disorder, disorders-of-excessive-somnolence, excessive-daytime-somnolence, mental-disorders, movement-disorders, myoclonus, narcolepsy, parasomnia, parkinson-disease, rem-sleep-behavior-disorder, restless-legs-syndrome, sleep-apnea-obstructive, sleep-apnea-syndromes, sleep-disorders, sleep-initiation-and-maintenance-disorders, sleeplessness.

Among the many pathways, these few ones have gauged particular interests from scientists studying Nocturnal Myoclonus Syndrome, and have been seen in publications frequently: Acute-phase Response, Aging, Circadian Rhythm, Excretion, Localization, Locomotion, Menopause, Pathogenesis, Reflex, Response To Olanzapine

Quite a number of genes have been found to play important roles in Nocturnal Myoclonus Syndrome, such as BTBD9, CENPJ, CFH, CTNNBL1, DIO2, FXYD1, GZMA, HTT, MAP2K5, NANS, NMS, PLA2G7, PSG5, RANGAP1, REST, RHO, RHOD, SLC17A5, TSPAN31, TST. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.